Frequency of Dyslipidemia In Type 2 Diabetic Patients In Karachi
DOI:
https://doi.org/10.51985/JBUMDC2018135Keywords:
coronary heart disease, Diabetes mellitus, dyslipidemia, HbA1C.Abstract
Objective: To find out the frequency of dyslipidemias in type 2 diabetic patients.
Study Design and Setting: This was cross-sectional study and conducted in a different clinics in Karachi during 3 months
period.
Methodology: Those patients who fulfilled the inclusion criteria and attended the OPD were selected. Patient were advised
to bring their lipid profile report in next visit if not already done. The total dyslipidemias were presented by their frequencies
and percentages with 95% confidence interval.
Results: Out of 383 patients with diabetes mellitus 210 (55 %) had dyslipidemia. Among which 76% had elevated lowdensity
lipoprotein (LDL), 66.6 % had elevated serum cholesterol, 57% patient had elevated triglyceride. p- value of 0.05
was taken as statistically significant.
Conclusion: It was concluded that increased frequency of dyslipidemias, with elevated low-density lipoprotein, cholesterol
and triglycerides levels seen in diabetic patients.
References
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice. 2014;103(2):137-49.
Maliha Sarfraz, Sanaullah Sajid, Muhammad Aqeel Ashraf. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi Journal of Biological Sciences. 2016; 23: 761-66.
Abou-Seif MA, Youssef AA: Evaluation of some biochemical changes in diabetic patients. Clinica Chimica Acta; International journal of Clinical Chemistry. 2004; 346(2): 161–170.
Seshasai SR, Kaptoge S. Diabetes mellitus, fasting glucose, and risk of cause specific death. New England Journal of medicine .2011;364:829-41.
Duckworth W, Araira C, Moritz T, Reda D. Glucose control and vascular complications in veterans with type 2 diabetes. New England journal of medicine.2009;360 (2):129-39.
Sarwar N, Gao P, Seshasai SR, Gobin Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. lancet.2010;375:2215-22.
Krishnaswami Vijayaraghavan. Treatment of dyslipidemia in patients with type 2 diabetes. Lipids in Health and Disease December 2010, 9(1):144
Taskinen MR. Diabetic dyslipidemia: from basic research to clinical practice. Diabetologia. 2003;46 (6):733–49.
Verges B. Pathophysiology of diabetic dyslipidemia: where are we? Diabetologia. 2015;58(5):886–99.
Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA. Islet Inflammation in Type 2 Diabetes: from metabolic stress to therapy. Diabetes Care 2008;31(2): S161–S64.
Lee SJ, Campos H, Maye LA, Sacks FM. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arteriosclerosis, Thrombosis and Vascular Biology. 2003;23(5):853–8.
Abbasi A, Corpeleijn E, Gansevoort RT. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in general population: the PREVEND study. The Journal of clinical endocrinology and metabolism 2013;98(8):1352-59.
Modi KD, Chandwani R, Ahmed I, Kumar KV. Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes. Diabetes and Metabolic Syndrome. 2016;10(1):99–102.
Morgantini C, Natali A, Boldrini B. Anti-inflammatory and antioxidant properties of HDL are impaired in type 2 diabetes. Diabetes.2011;60 (10):2617-23.
Thapa Subarna Dhoj, KC Shiva Raj, Gautam Santosh, Gyawali Deepika. Dyslipidemia in type 2 diabetes mellitus. Journal of Pathology of Nepal 2017: 1149 – 54.
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014; 384:626–35.
Agrawal Y, Goyal V, Chugh K, Shanker, V., Singh AA. Types of dyslipidemia in type 2 diabetic patients of Haryana region. Scholars journal of Applied Medical Sciences.2014; 2(4): 1385–92.
Udawat H, Goyal RK, Maheshwari S. Coronary risk and dyslipidemia in type 2 diabetic patients. The Journal of Association of the Physicians of India. oct 2001;49: 970–73.
Jayarama N, Reddy M, Lakshmanan V. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients in a rural tertiary care Centre, South India. The Global Journal of Medicine and public health home 2012; 1(3): 24.
Bali K, Singh A. Pattern of dyslipidemia in Type 2 Diabetes Mellitus in Punjab. International Journal of Research in Medical Sciences.2016;4(3):809-12.
Ahmad A, Khan J, Siddiqui TS. Frequency of dyslipidemia in type 2 diabetes mellitus in patients of Hazara division. Journal of Ayub Medical College, Abbottabad 2008; 20 (2): 51–4.
Kandula R, Shegokar VA . Study of lipid profile in patients with type 2 diabetes mellitus. Journal of Health Sciences. 1(1), 23–26.
Uttra KM, Devrajani BR, Shah SZA , Devrajani T, Das T, Raza S, Naseem. Lipid Profile of patients with Diabetes mellitus (a multidisciplinary study). World Applied Sciences Journal. 2011;12(9):1382–84.
Tagoe DNA, Amo-Kodieh P. Type 2 diabetes mellitus influences lipid profile of diabetic patients. Annals of Biological Research ,2013; 4(6): 88–92.
Nadeem A, Mumtaz Naveed AK et .al. Prevalence of dyslipidemia and impact of increasing age and duration of type 2 diabetes on dyslipidemia, insulin levels and insulin resistance. Jpma september 2015; 65(9)
M.Zaid, S.Hasnain . Plasma lipid abnormalities in Pakistani population: trends, associated factors, and clinical implications. Brazilian Journal of Medical Biological Research.2018; 51(9): e7239.
Muhammad Anwar1, Syed Raza Jaffar2, Aamir Ijaz3, Najamuddin1, Fawad Sana2.Evaluation of dyslipidaemia in type 2 diabetes mellitus patient. Pak journal of pathology. 2017: 28(3): 135-140.
McEneny J, O’Kane MJ, Moles KW, et al. Very low-density lipoprotein subfractions in type II diabetes mellitus: alterations in composition and susceptibility to oxidation. Diabetologia. 2000; 43:485–93.
Lotta LA, Sharp SJ, Burgess S, Perry JR, Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B. Association between low?density lipoprotein cholesterol?lowering genetic variants and risk of type 2 diabetes: a meta?analysis. JAMA. 2016;316(13):1383–91.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Sehrish Shafique, Daud Mirza, Summayya Shawana, Shahneela Tabassum, Naveed Faraz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
